Coronavirus: US approves use of remdesivir for treating Covid-19 despite WHO doubts

Coronavirus: US approves use of remdesivir for treating Covid-19 despite WHO doubts

Remdesivir, developed by Gilead Sciences, has been approved for use in the treatment of Covid-19 patients. Photo: EPA-EFERemdesivir, developed by Gilead Sciences, has been approved for use in the treatment of Covid-19 patients. Photo: EPA-EFE

Remdesivir, developed by Gilead Sciences, has been approved for use in the treatment of Covid-19 patients. Photo: EPA-EFE

  • Drug, sold under the brand name Veklury, approved for hospital use in adults and children aged 12 and above
  • WHO’s Solidarity trial, spanning 30 countries, found the drug had little effect on mortality, reducing the length of hospital stays or need for a ventilator

Topic |  
Coronavirus pandemic

Zhuang Pinghui

Updated: 8:06pm, 23 Oct, 2020

XL subscribe to our newsletter banner

Get the latest news and advice on COVID-19, direct from the experts in your inbox. Join hundreds of thousands who trust experts by subscribing to our newsletter.

Send your news and stories to us news@climaxradio.co.uk or newstories@climaxnewsroom.com and WhatsApp: +447747873668.

Before you go...

Democratic norms are being stress-tested all over the world, and the past few years have thrown up all kinds of questions we didn't know needed clarifying – how long is too long for a parliamentary prorogation? How far should politicians be allowed to intervene in court cases? To monitor these issues as closely as we have in the past we need your support, so please consider donating to The Climax News Room.

Leave a Reply

Your email address will not be published. Required fields are marked *